Clinical Trial Update: A Study on the Efficacy and Safety of Empagliflozin in the Treatment of Pulmonary Arterial Hypertension [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial is evaluating the efficacy and safety of empagliflozin for treatment of pulmonary arterial hypertension; the study is currently recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• Jardiance (empagliflozin)

Snippet

Sponsor: China National Center for Cardiovascular Diseases | Conditions: Pulmonary Arterial Hypertension | Phase 1 | Status: RECRUITING